X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
chemistry (18) 18
heterocyclic compounds (17) 17
human necessities (17) 17
hygiene (17) 17
medical or veterinary science (17) 17
metallurgy (17) 17
organic chemistry (17) 17
preparations for medical, dental, or toilet purposes (17) 17
index medicus (9) 9
humans (8) 8
agriculture (7) 7
animal husbandry (7) 7
animals (7) 7
biocides, e.g. as disinfectants, as pesticides, as herbicides (7) 7
fishing (7) 7
forestry (7) 7
hunting (7) 7
pest repellants or attractants (7) 7
plant growth regulators (7) 7
preservation of bodies of humans or animals or plants or partsthereof (7) 7
trapping (7) 7
mice (6) 6
specific therapeutic activity of chemical compounds ormedicinal preparations (6) 6
disease models, animal (5) 5
oncology (5) 5
cell line, tumor (4) 4
expression (4) 4
male (4) 4
xenograft model antitumor assays (4) 4
female (3) 3
gene expression (3) 3
ligands (3) 3
rats (3) 3
receptors, androgen - metabolism (3) 3
signal transduction - drug effects (3) 3
transcription (3) 3
tumor burden - drug effects (3) 3
androgen antagonists - pharmacology (2) 2
biochemistry (2) 2
breast cancer (2) 2
cancer (2) 2
cell proliferation - drug effects (2) 2
cells (2) 2
cells, cultured (2) 2
dihydrotestosterone (2) 2
dna microarrays (2) 2
estrogen receptor beta - agonists (2) 2
estrogen receptor beta - metabolism (2) 2
estrogen receptor-beta (2) 2
gene expression regulation, neoplastic - drug effects (2) 2
gene-expression (2) 2
health aspects (2) 2
inhibition (2) 2
kinases (2) 2
medicine (2) 2
mice, nude (2) 2
multidisciplinary sciences (2) 2
ophthalmology (2) 2
p38 mitogen-activated protein kinases - metabolism (2) 2
phosphorylation (2) 2
phosphorylation - drug effects (2) 2
prevents bone loss (2) 2
prostatic neoplasms - genetics (2) 2
prostatic neoplasms - metabolism (2) 2
r&d (2) 2
receptors, androgen - genetics (2) 2
research & development (2) 2
research & development--r&d (2) 2
research article (2) 2
science (2) 2
small heterodimer partner (2) 2
target (2) 2
tumor burden - genetics (2) 2
17-beta-estradiol (1) 1
3-hydroxysteroid dehydrogenases - antagonists & inhibitors (1) 1
3-hydroxysteroid dehydrogenases - genetics (1) 1
3-hydroxysteroid dehydrogenases - metabolism (1) 1
activated protein-kinase (1) 1
activation (1) 1
acyclic or carbocyclic compounds (1) 1
adenosine triphosphate - metabolism (1) 1
adipose-tissue (1) 1
adrenal androgens (1) 1
age-related maculopathy (1) 1
air (1) 1
aldo-keto reductase family 1 member c3 (1) 1
aldo-keto reductases (1) 1
alpha (1) 1
amides - pharmacology (1) 1
anabolic agents - pharmacology (1) 1
analysis (1) 1
androgen receptor antagonists (1) 1
androgens (1) 1
androgens - metabolism (1) 1
androgens - pharmacology (1) 1
androstanediol (1) 1
angiogenesis (1) 1
angiogenesis inhibitors - pharmacology (1) 1
anilides - pharmacology (1) 1
animal tissues (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (29) 29
French (7) 7
German (3) 3
Chinese (2) 2
Japanese (1) 1
Korean (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 07/2014, Volume 9, Issue 7, pp. e103202 - e103202
Introduction: The androgen receptor (AR) is the most highly expressed steroid receptor in breast cancer with 75-95% of estrogen receptor (ER)-positive and... 
ACTIVATION | THERAPY | ENOBOSARM | PROSTATE-SPECIFIC ANTIGEN | TAMOXIFEN | MULTIDISCIPLINARY SCIENCES | TRANSCRIPTION | PHYSICAL FUNCTION | DOUBLE-BLIND | EXPRESSION | PREVENTS BONE LOSS | Mesenchymal Stromal Cells - drug effects | Humans | Receptors, Androgen - metabolism | Mesenchymal Stromal Cells - metabolism | Xenograft Model Antitumor Assays | Neoplasm Metastasis | Animals | Triple Negative Breast Neoplasms - genetics | Signal Transduction - drug effects | Tumor Burden - drug effects | Mice, Nude | Triple Negative Breast Neoplasms - metabolism | Paracrine Communication - drug effects | Triple Negative Breast Neoplasms - pathology | Cell Line, Tumor | Female | Cell Proliferation - drug effects | Mice | Gene Expression Regulation, Neoplastic - drug effects | Selective Estrogen Receptor Modulators - pharmacology | Disease Models, Animal | Androgens | DNA microarrays | Growth | Analysis | Stem cells | Estrogen | Development and progression | Breast cancer | Metastasis | Tumor proteins | Tamoxifen | Health aspects | Cell culture | Mesenchyme | p53 Protein | Estrogens | Estrogen receptors | Paracrine signalling | Fuel consumption | Kinases | Cancer therapies | Modulators | Metastases | Interleukin 6 | Proteins | Dihydrotestosterone | Historical account | Inhibition | Research & development--R&D | Cyclin-dependent kinases | Gene expression | Collagenase 3 | Augmented reality | Side effects | Womens health | Weight reduction | Breast | PTEN protein | Tumors | Cancer | Index Medicus | Research & development | R&D
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2013, Volume 8, Issue 12, pp. e83380 - e83380
Receptor tyrosine kinases (RTKs), in response to their growth factor ligands, phosphorylate and activate downstream signals important for physiological... 
CELLS | GLIOBLASTOMA | MULTIDISCIPLINARY SCIENCES | MOUSE | AIR | NGF | EXPRESSION | PSORIASIS | NERVE GROWTH-FACTOR | Neoplasms - metabolism | NIH 3T3 Cells | Humans | Receptor, trkA - antagonists & inhibitors | Dermatitis, Atopic - chemically induced | Inflammation - metabolism | Neoplasms - genetics | Inflammation - drug therapy | Anti-Inflammatory Agents - therapeutic use | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Tumor Burden - genetics | Phosphorylation - drug effects | Disease Models, Animal | Proto-Oncogene Proteins - metabolism | Proto-Oncogene Proteins - antagonists & inhibitors | Gene Expression | Anti-Inflammatory Agents - pharmacology | Rats | Proto-Oncogene Proteins - genetics | Receptor Protein-Tyrosine Kinases - metabolism | Neoplasms - drug therapy | Xenograft Model Antitumor Assays | Animals | Dermatitis, Atopic - drug therapy | Receptor Protein-Tyrosine Kinases - genetics | Receptor, trkA - metabolism | Signal Transduction - drug effects | Tumor Burden - drug effects | Protein Kinase Inhibitors - therapeutic use | Cell Line, Tumor | Inflammation - genetics | Receptor, trkA - genetics | Mice | Protein Kinase Inhibitors - pharmacology | Neoplasms - pathology | Tyrosine | Nervous system diseases | Care and treatment | Oncology, Experimental | Inflammation | Research | Atopic dermatitis | Phenols | Drug therapy | Comparative analysis | Gene therapy | Health aspects | Phosphotransferases | Cancer | Phosphorylation | Physiological effects | Transformation | Transcription factors | Authorship | Lung cancer | Neuropathy | Kinases | Dermatitis | Neuroblastoma cells | Ret protein | Pain | Animal tissues | Cell cycle | Tumor necrosis factor-TNF | Inhibition | Chemical synthesis | Growth factors | Protein-tyrosine kinase | Immunoglobulins | Psoriasis | Neurodegenerative diseases | Research & development--R&D | Breast cancer | Neurological diseases | Overexpression | DNA microarrays | Volatile organic compounds--VOCs | Mutation | Index Medicus | Research & development | VOCs | Volatile organic compounds | R&D
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 10/2013, Volume 19, Issue 20, pp. 5613 - 5625
Journal Article
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 10/2010, Volume 285, Issue 41, pp. 31292 - 31303
Obesity is an epidemic problem affecting millions of people in the Western hemisphere and costs the United States economy more than $200 billion annually.... 
TARGET | SMALL HETERODIMER PARTNER | METABOLIC SYNDROME | INSULIN-RESISTANCE | BIOCHEMISTRY & MOLECULAR BIOLOGY | DISEASE | GENE-EXPRESSION | WEIGHT-LOSS | PPAR-GAMMA | ALPHA | ADIPOSE-TISSUE | Gene Regulation | Molecular Bases of Disease | Obesity | Drug Design | Metabolic Diseases | Steroid Hormone Receptor | Estrogen Receptor-beta | Steroid Hormone
Journal Article
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 02/2013, Volume 31, Issue 6, pp. 100 - 100
Conference Proceeding
04/2017
The present invention relates to methods for prevention and/or treatment of metabolic disorders, post-menopausal obesity and conditions associated with high... 
HYGIENE | METALLURGY | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | ORGANIC CHEMISTRY | CHEMISTRY | MEDICAL OR VETERINARY SCIENCE | HETEROCYCLIC COMPOUNDS | HUMAN NECESSITIES
Patent
01/2017
The present application relates to methods of treating, preventing, delaying the onset of, reducing the incidence of, or reducing the severity of fibrosis,... 
HYGIENE | METALLURGY | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | ORGANIC CHEMISTRY | CHEMISTRY | MEDICAL OR VETERINARY SCIENCE | HETEROCYCLIC COMPOUNDS | HUMAN NECESSITIES
Patent
01/2016
PROBLEM TO BE SOLVED: To provide chemical compounds useful for prevention and treatment of diseases associated with metabolic disorder, post-menopausal obesity... 
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS | HYGIENE | METALLURGY | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | ORGANIC CHEMISTRY | CHEMISTRY | MEDICAL OR VETERINARY SCIENCE | HETEROCYCLIC COMPOUNDS | HUMAN NECESSITIES
Patent
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.